Clinical Trials Logo

Alcoholism clinical trials

View clinical trials related to Alcoholism.

Filter by:
  • Active, not recruiting  
  • « Prev · Page 7

NCT ID: NCT01182766 Active, not recruiting - Nicotine Dependence Clinical Trials

New Treatment for Alcohol and Nicotine Dependence

Start date: September 2011
Phase: Phase 2/Phase 3
Study type: Interventional

This research study aims to test whether topiramate (a drug that is being used for seizure) will help individuals who have problems with both alcohol and nicotine. The investigators believe that individuals taking topiramate will be more successful at abstaining from both alcohol and nicotine than individuals taking placebo.

NCT ID: NCT00802412 Active, not recruiting - Nicotine Dependence Clinical Trials

Topiramate to Aid Smoking Cessation in Alcohol Dependent Men

Start date: January 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether topiramate is effective as an aid to smoking cessation for recovering alcohol dependent men.

NCT ID: NCT00608686 Active, not recruiting - Clinical trials for Alcohol Intoxication

Neurosteroids and Acute Alcohol Intoxication in Humans

Start date: May 2004
Phase: Phase 1
Study type: Interventional

1. The major aims are to assess: (1) the relationship of basal and alcohol-induced neurosteroid and GABA levels to the degree of acute alcohol intoxication in healthy male and female volunteers; and (2) the effect of acute pregnenolone administration on the degree of acute alcohol intoxication in these same volunteers. Specific hypotheses are: - Baseline serum levels of pregnenolone, pregnenolone sulfate (PS), dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEA-S) will be inversely correlated with the magnitude of acute behavioral responses to alcohol (sedation, anxiolysis, amnesia, psychomotor impairment and intoxication). That is, higher baseline levels of these neurosteroids will be associated with lessened behavioral responses to alcohol. - Baseline serum levels of allopregnanolone, tetrahydrodeoxycorticosterone (THDOC), androstanediol, androsterone and GABA will be directly correlated with the magnitude of acute behavioral responses to alcohol. That is, higher baseline levels of these substances will be associated with heightened behavioral responses to alcohol. - Acute alcohol ingestion, compared to placebo ingestion, will increase serum levels of allopregnanolone and THDOC and plasma levels of GABA and will decrease plasma levels of PS. (Effects on levels of other neurosteroids are not specifically predicted based on animal data but will be examined in an exploratory manner.) - Acute alcohol-induced increases in serum levels of allopregnanolone and THDOC and in plasma levels of GABA will be directly correlated with the magnitude of acute behavioral responses to alcohol. Acute alcohol-induced decreases in serum levels of PS will be directly correlated with the magnitude of acute behavioral responses to alcohol. Correlations between alcohol-induced changes in other neurosteroids and changes in behavior are not specifically predicted but will be examined in an exploratory manner. - Pregnenolone, compared to placebo, pre-treatment will antagonize the acute effects of alcohol on the behavioral measures.

NCT ID: NCT00484367 Active, not recruiting - Alcohol Dependence Clinical Trials

A Comparison of Adolescent Group Therapy and Transitional Family Therapy for Adolescent Alcohol and Drug Abusers

Start date: July 1999
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to compare the effectiveness of two psychosocially-based, manual-driven, behavioral modalities. One of these is a standardized version of the established modality of Adolescent Group Therapy (AGT), which includes both psychoeducational and therapeutic components. The other is a state-of-the-art family therapy approach, Transitional Family Therapy (TFT), which integrates management of the current problem with exploration of multigenerational issues. Both approaches have been developed to expressly target adolescent alcohol problems.

NCT ID: NCT00280488 Active, not recruiting - Alcohol Dependence Clinical Trials

Enhanced Motivational Interviewing With Alcohol Positive Trauma Patients

Start date: May 2005
Phase: Phase 3
Study type: Interventional

The primary goal of this study is to test the efficacy of a brief intervention that includes the patient and a significant other, relative to an intervention including the patient only, for reducing alcohol use and alcohol-related problems among trauma patients.

NCT ID: NCT00246428 Active, not recruiting - Alcohol Dependence Clinical Trials

Motivational Interviewing for Alcohol-Positive Teens in the Emergency Room

Start date: January 2000
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether motivational interviewing is effective in reducing alcohol consumption and alcohol problems among young adults who present to an Emergency Room.

NCT ID: NCT00120601 Active, not recruiting - Alcoholism Clinical Trials

Trial for the Treatment of Alcohol Dependence

Start date: March 2003
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the effectiveness of two anti-craving medications, naltrexone versus acamprosate, in the treatment of alcohol dependence.